Pacira Pharmaceuticals, Inc.【PCRX】 減価償却費の推移

機能の使い方
(単位:千ドル) 減価償却費 前年比(%)
2024/12 78,785 +4.2%
2023/12 75,574 -17.4%
2022/12 91,501 +220.5%
2021/12 28,548 +43.4%
2020/12 19,908 +1.7%
2019/12 19,576 +48.7%
2018/12 13,165 -4.8%
2017/12 13,833 +7.1%
2016/12 12,919 +12.6%
2015/12 11,475 +14.3%
2014/12 10,035 +74.6%
2013/12 5,747 +1.8%
2012/12 5,648 +30.9%
2011/12 4,314 -